Alper Guzeltas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alper Guzeltas has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Erkut Ozturk
Department of Pediatric Cardiology, Saglik Bilimleri University, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Turkey
20 shared publications - Selman Gokalp
Department of Pediatric Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul 34303, Türkiye
20 shared publications - Sertaç Haydin
Department of Pediatric Cardiovascular Surgery, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye
20 shared publications - Sezen Ugan Atik
Department of Pediatric Cardiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul
19 shared publications - Yakup Ergul
University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center
18 shared publications - Ibrahim Cansaran Tanidir
Pediatric Cardiology Department Ministry of Health University Başakşehir Çam and Sakura City Hospital İstanbul Türkiye
15 shared publications
Latest Publications
- Open Access
- 24 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3484
Beyond the Segmental Code: Anatomic Diversity and Surgical Pathways in Left Atrial Appendage Isomerism with the {A,L,I} Combination
Background/Objectives: Left atrial appendage isomerism (LAAI) is associated with substantial variation in venous connections and intracardiac anatomy. A subgroup of LAAI patients has L-loop ventricular topology together with a particular great artery relationship—a combination that corresponds historically to Van Praagh’s {A,L,I} segmental notation—but this subgroup has not been separately characterized. We aimed to describe the anatomical spectrum, rhythm and conduction abnormalities, biventricular repair eligibility, and surgical pathways in this subgroup. Methods: This single-center retrospective study included 15 patients with LAAI, L-loop ventricular topology, and a specific great artery relationship (aorta left-sided, pulmonary artery right-sided)—a combination corresponding historically to Van Praagh’s {A,L,I} notation—evaluated between January 2010 and December 2025. Diagnosis was confirmed independently by echocardiography and cardiac computed tomography in all patients. Anatomical suitability for biventricular repair was determined by multidisciplinary consensus. Results: Median age at presentation was 3.0 months, and median follow-up was 31.0 months. An interrupted inferior vena cava was present in all patients. The great artery relationship was aorta left-posterior/pulmonary artery right-anterior in 12 patients, aorta left-anterior/pulmonary artery right-posterior in 2, and side-by-side in 1. Ventriculoarterial connection was concordant in 8 patients, double-outlet right ventricle in 6, and double-outlet left ventricle in 1. A common atrioventricular valve was present in 7 patients. Right ventricular outflow tract obstruction was present in 7 patients. Arrhythmia was documented in 6 patients, and 2 required permanent pacemaker implantation. Ten patients (66.7%) were considered anatomically eligible for biventricular repair; repair had been completed in 4, 2 had received interim palliation, and 4 remained awaiting surgery. The remaining 4 patients followed a single-ventricle pathway. One death was confirmed, and 2 patients were lost to follow-up. Conclusions: Within LAAI, the coexistence of L-loop ventricular topology and a specific great artery relationship was associated with ventriculoarterial concordance in most patients, which may support biventricular repair. Anatomical eligibility for repair, however, did not always translate into completed repair. Larger, multicenter studies are needed to confirm these findings.
- 24 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3484
Open AccessBeyond the Segmental Code: Anatomic Diversity and Surgical Pathways in Left Atrial Appendage Isomerism with the {A,L,I} Combination
Background/Objectives: Left atrial appendage isomerism (LAAI) is associated with substantial variation in venous connections and intracardiac anatomy. A subgroup of LAAI patients has L-loop ventricular topology together with a particular great artery relationship—a combination that corresponds historically to Van Praagh’s {A,L,I} segmental notation—but this subgroup has not been separately characterized. We aimed to describe the anatomical spectrum, rhythm and conduction abnormalities, biventricular repair eligibility, and surgical pathways in this subgroup. Methods: This single-center retrospective study included 15 patients with LAAI, L-loop ventricular topology, and a specific great artery relationship (aorta left-sided, pulmonary artery right-sided)—a combination corresponding historically to Van Praagh’s {A,L,I} notation—evaluated between January 2010 and December 2025. Diagnosis was confirmed independently by echocardiography and cardiac computed tomography in all patients. Anatomical suitability for biventricular repair was determined by multidisciplinary consensus. Results: Median age at presentation was 3.0 months, and median follow-up was 31.0 months. An interrupted inferior vena cava was present in all patients. The great artery relationship was aorta left-posterior/pulmonary artery right-anterior in 12 patients, aorta left-anterior/pulmonary artery right-posterior in 2, and side-by-side in 1. Ventriculoarterial connection was concordant in 8 patients, double-outlet right ventricle in 6, and double-outlet left ventricle in 1. A common atrioventricular valve was present in 7 patients. Right ventricular outflow tract obstruction was present in 7 patients. Arrhythmia was documented in 6 patients, and 2 required permanent pacemaker implantation. Ten patients (66.7%) were considered anatomically eligible for biventricular repair; repair had been completed in 4, 2 had received interim palliation, and 4 remained awaiting surgery. The remaining 4 patients followed a single-ventricle pathway. One death was confirmed, and 2 patients were lost to follow-up. Conclusions: Within LAAI, the coexistence of L-loop ventricular topology and a specific great artery relationship was associated with ventriculoarterial concordance in most patients, which may support biventricular repair. Anatomical eligibility for repair, however, did not always translate into completed repair. Larger, multicenter studies are needed to confirm these findings.
- Open Access
- 21 October 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (3) , 188-195
Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery Beyond Infancy: Single-Center Experience of Clinical Spectrum and Surgical Outcomes
Objective: Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare and life-threatening congenital anomaly. While it typically manifests during early infancy, some patients remain asymptomatic or present later in childhood and adolescence due to well-developed intercoronary collaterals. Therefore, the objective of this study was to evaluate the clinical spectrum, diagnostic features, and surgical outcomes of patients diagnosed with ALCAPA beyond infancy at our center. Methods: A retrospective review was conducted on 35 patients diagnosed with ALCAPA who underwent surgical treatment at our center between January 2012 and January 2025. Out of this cohort, 8 patients diagnosed beyond infancy (older than 12 months) were enrolled in this study to evaluate their clinical spectrum and surgical revascularization outcomes. Results: The age at diagnosis ranged from 2 to 21 years (median: 6.8 years), and all patients were female. Four patients (50%) were completely asymptomatic at presentation. Symptomatic presentations included exertional chest pain (n=1), recurrent vomiting and irritability (n=2), and sudden cardiac arrest with sustained ventricular arrhythmia (n=1). Electrocardiography (ECG) revealed characteristic ALCAPA patterns in 5 patients. Echocardiography demonstrated left ventricular (LV) and right coronary artery (RCA) dilation in all cases, with a mean RCA/aortic annulus ratio of 0.25. Baseline LV systolic dysfunction (ejection fraction: 30–45%) was observed in 4 patients. Surgical management consisted of direct coronary reimplantation (n=6) and the Takeuchi procedure (n=2). Mitral valve repair was performed in 2 patients with structural mitral anomalies. At a mean follow-up of 48 months, all patients were alive and asymptomatic, with full recovery of LV function and resolution of ECG abnormalities within 6–9 months postoperatively. Conclusion: ALCAPA must be considered in the differential diagnosis of unexplained LV dilation or mitral regurgitation across all pediatric age groups. Extensive collateral circulation can mask typical features, leading to atypical presentations or misdiagnosis. Prompt establishment of a dual-coronary system provides a satisfactoryprognosis and facilitates complete myocardial recovery.
- 21 October 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (3) , 188-195
Open AccessAnomalous Origin of the Left Coronary Artery from the Pulmonary Artery Beyond Infancy: Single-Center Experience of Clinical Spectrum and Surgical Outcomes
Objective: Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare and life-threatening congenital anomaly. While it typically manifests during early infancy, some patients remain asymptomatic or present later in childhood and adolescence due to well-developed intercoronary collaterals. Therefore, the objective of this study was to evaluate the clinical spectrum, diagnostic features, and surgical outcomes of patients diagnosed with ALCAPA beyond infancy at our center. Methods: A retrospective review was conducted on 35 patients diagnosed with ALCAPA who underwent surgical treatment at our center between January 2012 and January 2025. Out of this cohort, 8 patients diagnosed beyond infancy (older than 12 months) were enrolled in this study to evaluate their clinical spectrum and surgical revascularization outcomes. Results: The age at diagnosis ranged from 2 to 21 years (median: 6.8 years), and all patients were female. Four patients (50%) were completely asymptomatic at presentation. Symptomatic presentations included exertional chest pain (n=1), recurrent vomiting and irritability (n=2), and sudden cardiac arrest with sustained ventricular arrhythmia (n=1). Electrocardiography (ECG) revealed characteristic ALCAPA patterns in 5 patients. Echocardiography demonstrated left ventricular (LV) and right coronary artery (RCA) dilation in all cases, with a mean RCA/aortic annulus ratio of 0.25. Baseline LV systolic dysfunction (ejection fraction: 30–45%) was observed in 4 patients. Surgical management consisted of direct coronary reimplantation (n=6) and the Takeuchi procedure (n=2). Mitral valve repair was performed in 2 patients with structural mitral anomalies. At a mean follow-up of 48 months, all patients were alive and asymptomatic, with full recovery of LV function and resolution of ECG abnormalities within 6–9 months postoperatively. Conclusion: ALCAPA must be considered in the differential diagnosis of unexplained LV dilation or mitral regurgitation across all pediatric age groups. Extensive collateral circulation can mask typical features, leading to atypical presentations or misdiagnosis. Prompt establishment of a dual-coronary system provides a satisfactoryprognosis and facilitates complete myocardial recovery.
- Open Access
- 26 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6586
Clinical Course and Surgical Outcomes of Patients with Tetralogy of Fallot with Absent Pulmonary Valve Syndrome: A Single-Center Retrospective Study
Background: Tetralogy of Fallot with absent pulmonary valve syndrome (TOF-APVS) is a rare variant of tetralogy of Fallot marked by aneurysmal pulmonary artery dilatation and variable tracheobronchial compression. The identification of clinical indicators that predict perioperative risk in this patient population remains challenging. We aimed to review the surgical outcomes and reintervention requirements of patients with TOF-APVS over a 15-year single-center experience, with particular focus on two indicators of disease severity: preoperative mechanical ventilation (MV) and computed tomography (CT)-detected airway compression. Methods: We retrospectively reviewed 27 patients with TOF-APVS who underwent surgical repair at a single center between January 2010 and January 2025. Airway compression was assessed by CT in 20 patients. The primary outcome was the need for any reintervention during follow-up. Secondary outcomes comprised early and overall mortality and postoperative duration of intubation, ICU stay, and hospital stay. Subgroup comparisons were performed using the Fisher exact test and the Mann–Whitney U test. Results: The median age at surgery was 8 months (IQR, 4.5–16). Preoperative MV was required in 5 patients (18.5%), and CT revealed airway compression in 13 of 20 patients (65.0%). Early postoperative mortality was 7.4%, and overall mortality during follow-up was 18.5%. At least one reintervention was required in 9 patients (33.3%). Preoperative MV was significantly associated with early mortality (40.0% vs. 0%; p = 0.028) and with prolonged ICU stay (median 15 vs. 4 days; p = 0.008). CT-detected airway compression was not significantly associated with either mortality or reintervention. Conclusions: In this 15-year single-center experience with 27 patients, preoperative mechanical ventilation was associated with markedly higher early postoperative mortality and prolonged ICU stay, and may thus serve as a practical clinical indicator of disease severity in TOF-APVS. CT-detected airway compression was a frequent and often severe finding, but its association with early mortality and reintervention could not be statistically confirmed, likely reflecting the selective use of CT and small subgroup size. These findings support the integration of preoperative ventilation status into perioperative risk assessment and highlight the need for larger, preferably multicenter, studies with standardized airway assessment to clarify the prognostic role of anatomical airway compression.
- 26 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6586
Open AccessClinical Course and Surgical Outcomes of Patients with Tetralogy of Fallot with Absent Pulmonary Valve Syndrome: A Single-Center Retrospective Study
Background: Tetralogy of Fallot with absent pulmonary valve syndrome (TOF-APVS) is a rare variant of tetralogy of Fallot marked by aneurysmal pulmonary artery dilatation and variable tracheobronchial compression. The identification of clinical indicators that predict perioperative risk in this patient population remains challenging. We aimed to review the surgical outcomes and reintervention requirements of patients with TOF-APVS over a 15-year single-center experience, with particular focus on two indicators of disease severity: preoperative mechanical ventilation (MV) and computed tomography (CT)-detected airway compression. Methods: We retrospectively reviewed 27 patients with TOF-APVS who underwent surgical repair at a single center between January 2010 and January 2025. Airway compression was assessed by CT in 20 patients. The primary outcome was the need for any reintervention during follow-up. Secondary outcomes comprised early and overall mortality and postoperative duration of intubation, ICU stay, and hospital stay. Subgroup comparisons were performed using the Fisher exact test and the Mann–Whitney U test. Results: The median age at surgery was 8 months (IQR, 4.5–16). Preoperative MV was required in 5 patients (18.5%), and CT revealed airway compression in 13 of 20 patients (65.0%). Early postoperative mortality was 7.4%, and overall mortality during follow-up was 18.5%. At least one reintervention was required in 9 patients (33.3%). Preoperative MV was significantly associated with early mortality (40.0% vs. 0%; p = 0.028) and with prolonged ICU stay (median 15 vs. 4 days; p = 0.008). CT-detected airway compression was not significantly associated with either mortality or reintervention. Conclusions: In this 15-year single-center experience with 27 patients, preoperative mechanical ventilation was associated with markedly higher early postoperative mortality and prolonged ICU stay, and may thus serve as a practical clinical indicator of disease severity in TOF-APVS. CT-detected airway compression was a frequent and often severe finding, but its association with early mortality and reintervention could not be statistically confirmed, likely reflecting the selective use of CT and small subgroup size. These findings support the integration of preoperative ventilation status into perioperative risk assessment and highlight the need for larger, preferably multicenter, studies with standardized airway assessment to clarify the prognostic role of anatomical airway compression.
- Open Access
- 22 July 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (7) , 1541
Sacubitril/valsartan in paediatric cardiomyopathy: a retrospective evaluation of ventricular response and clinical outcomes – CORRIGENDUM
- 22 July 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (7) , 1541
Open AccessSacubitril/valsartan in paediatric cardiomyopathy: a retrospective evaluation of ventricular response and clinical outcomes – CORRIGENDUM
- 23 June 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (6) , 1187-1196
Sacubitril/valsartan in paediatric cardiomyopathy: a retrospective evaluation of ventricular response and clinical outcomes
Background: Sacubitril/valsartan is widely used in adults with heart failure with reduced ejection fraction, but paediatric experience, especially across ventricular dysfunction phenotypes, remains limited. Aim: To evaluate the efficacy and tolerability of sacubitril/valsartan in children with cardiomyopathy and compare outcomes in patients with predominantly right or left ventricular dysfunction. Methods: This single-centre retrospective study included 33 patients aged 1 month to 18 years who received sacubitril/valsartan between October 2020 and October 2024. Diagnoses included arrhythmogenic right ventricular cardiomyopathy, left ventricular non-compaction, and dilated cardiomyopathy. Patients were stratified by predominant ventricular dysfunction. Echocardiographic parameters, N-terminal pro B-type natriuretic peptide, six-minute walk test, NYHA class, blood pressure, creatinine, and potassium were recorded at baseline and at 1, 3, and 6 months, and at final follow-up. Clinical outcomes included rehospitalisation, death, and heart transplantation or listing. Results: The cohort included 21 male patients (63.6%), and the median age was 8.6 years. Arrhythmogenic right ventricular cardiomyopathy was present in 45.5%, left ventricular non-compaction in 15.2%, and dilated cardiomyopathy in 39.4%. Left ventricular ejection fraction >45% increased from 39.4% to 72.7%. Mean N-terminal pro B-type natriuretic peptide decreased from 6309 to 3137 pg/mL ( p < 0.001). NYHA class improved or remained stable in 93.3% of patients, with greater improvement in left ventricular dysfunction. During a median 17.3-months follow-up, rehospitalisation occurred in 42.4%, and 5 patients died or underwent heart transplantation/listing. Hypotension occurred in 18.2% but was manageable. Conclusion: Sacubitril/valsartan was generally well tolerated and associated with improved ventricular function, biomarkers, and functional status in paediatric cardiomyopathy, particularly in left ventricular dysfunction.
- 23 June 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (6) , 1187-1196
Sacubitril/valsartan in paediatric cardiomyopathy: a retrospective evaluation of ventricular response and clinical outcomes
Background: Sacubitril/valsartan is widely used in adults with heart failure with reduced ejection fraction, but paediatric experience, especially across ventricular dysfunction phenotypes, remains limited. Aim: To evaluate the efficacy and tolerability of sacubitril/valsartan in children with cardiomyopathy and compare outcomes in patients with predominantly right or left ventricular dysfunction. Methods: This single-centre retrospective study included 33 patients aged 1 month to 18 years who received sacubitril/valsartan between October 2020 and October 2024. Diagnoses included arrhythmogenic right ventricular cardiomyopathy, left ventricular non-compaction, and dilated cardiomyopathy. Patients were stratified by predominant ventricular dysfunction. Echocardiographic parameters, N-terminal pro B-type natriuretic peptide, six-minute walk test, NYHA class, blood pressure, creatinine, and potassium were recorded at baseline and at 1, 3, and 6 months, and at final follow-up. Clinical outcomes included rehospitalisation, death, and heart transplantation or listing. Results: The cohort included 21 male patients (63.6%), and the median age was 8.6 years. Arrhythmogenic right ventricular cardiomyopathy was present in 45.5%, left ventricular non-compaction in 15.2%, and dilated cardiomyopathy in 39.4%. Left ventricular ejection fraction >45% increased from 39.4% to 72.7%. Mean N-terminal pro B-type natriuretic peptide decreased from 6309 to 3137 pg/mL ( p < 0.001). NYHA class improved or remained stable in 93.3% of patients, with greater improvement in left ventricular dysfunction. During a median 17.3-months follow-up, rehospitalisation occurred in 42.4%, and 5 patients died or underwent heart transplantation/listing. Hypotension occurred in 18.2% but was manageable. Conclusion: Sacubitril/valsartan was generally well tolerated and associated with improved ventricular function, biomarkers, and functional status in paediatric cardiomyopathy, particularly in left ventricular dysfunction.
- 2 March 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 616-618
Thoracıc duct reroutıng for Fontan faılure–assocıated lymphatıc dısease: a case report
Fontan-associated lymphatic failure may result in severe complications such as plastic bronchitis. We report a 6-year-old Fontan patient with refractory plastic bronchitis despite catheter-based interventions. Surgical thoracic duct decompression via innominate vein rerouting to the right atrium resulted in marked symptomatic improvement and resolution of bronchial cast expectoration, highlighting its role in refractory Fontan-related lymphatic disease.
- 2 March 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 616-618
Thoracıc duct reroutıng for Fontan faılure–assocıated lymphatıc dısease: a case report
Fontan-associated lymphatic failure may result in severe complications such as plastic bronchitis. We report a 6-year-old Fontan patient with refractory plastic bronchitis despite catheter-based interventions. Surgical thoracic duct decompression via innominate vein rerouting to the right atrium resulted in marked symptomatic improvement and resolution of bronchial cast expectoration, highlighting its role in refractory Fontan-related lymphatic disease.
- 19 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 231-236
Transcatheter extracardiac Fontan completion: a minimally invasive pathway for single-ventricle care
Background: Transcatheter completion of the extracardiac Fontan provides a minimally invasive option for selected children with single-ventricle physiology who have undergone staged preparation at the time of the bidirectional cavopulmonary connection. Methods: We performed a retrospective single-centre review of consecutive patients treated between 2022 and 2025. Candidate selection, cross-sectional imaging, diagnostic catheterisation, procedural steps, early recovery, and follow-up outcomes were collected. Results: Five patients underwent transcatheter completion at a median age of 7 years (range 4–17). The interval between the preparatory operation and catheter procedure was 7 months (range 6–9). Median procedure time was 140 minutes (range 120–180). The ICU stay was 2 days (range 1–3), and the total hospital stay was 5 days (range 4–6). Minimal pleural effusions occurred in four patients, none requiring drainage. At a median follow-up of 28 months (range 4–36), all patients were clinically stable; resting oxygen saturation was 96% (range 94% to 97%). One late-presenting patient had biochemical evidence consistent with protein-losing enteropathy but remained asymptomatic without targeted therapy. No thromboembolic events occurred. Conclusions: In a programme that couples surgical preparation with later catheter-based completion, the extracardiac Fontan can be performed safely and effectively in carefully selected candidates, with rapid recovery and stable mid-term clinical status. Larger studies are needed to define long-term outcomes and comparative effectiveness versus surgical completion.
- 19 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 231-236
Transcatheter extracardiac Fontan completion: a minimally invasive pathway for single-ventricle care
Background: Transcatheter completion of the extracardiac Fontan provides a minimally invasive option for selected children with single-ventricle physiology who have undergone staged preparation at the time of the bidirectional cavopulmonary connection. Methods: We performed a retrospective single-centre review of consecutive patients treated between 2022 and 2025. Candidate selection, cross-sectional imaging, diagnostic catheterisation, procedural steps, early recovery, and follow-up outcomes were collected. Results: Five patients underwent transcatheter completion at a median age of 7 years (range 4–17). The interval between the preparatory operation and catheter procedure was 7 months (range 6–9). Median procedure time was 140 minutes (range 120–180). The ICU stay was 2 days (range 1–3), and the total hospital stay was 5 days (range 4–6). Minimal pleural effusions occurred in four patients, none requiring drainage. At a median follow-up of 28 months (range 4–36), all patients were clinically stable; resting oxygen saturation was 96% (range 94% to 97%). One late-presenting patient had biochemical evidence consistent with protein-losing enteropathy but remained asymptomatic without targeted therapy. No thromboembolic events occurred. Conclusions: In a programme that couples surgical preparation with later catheter-based completion, the extracardiac Fontan can be performed safely and effectively in carefully selected candidates, with rapid recovery and stable mid-term clinical status. Larger studies are needed to define long-term outcomes and comparative effectiveness versus surgical completion.
- 1 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 380-385
The role of interatrial stenting in the management of CHD
Background: Interatrial stenting has become an essential intervention for children with CHD requiring sustained interatrial communication to optimise systemic and pulmonary haemodynamics. This study aimed to evaluate procedural success, clinical outcomes, and factors influencing haemodynamic improvement in a single-centre paediatric cohort. Methods: A retrospective study was conducted on 16 patients who underwent interatrial stenting between 2018 and 2024. Patients were categorised by age as Group 1 (≤12 months, n = 10) and Group 2 (>12 months, n = 6). Demographic, procedural parameters, and follow-up data were analysed. Results: Sixteen patients (median age 10.5 months, median weight 5.0 kg) underwent interatrial stenting. The most frequent diagnosis was borderline left ventricle (37.5%), followed by hypoplastic left heart syndrome (25%) and myocarditis (12.5%). Procedural success was achieved in 15 of 16 patients (93.8%), with one acute failure due to stent embolisation. The median radiation exposure was 244.5 mGy (interquartile range 123.8–447.0). Radiation exposure correlated positively with patient weight (r s = 0.596, p = 0.015). During a median follow-up of 17.5 months, six patients (37.5%) died, and two required redilation. No stent thrombosis occurred. Conclusion: Interatrial stenting is a safe and effective palliative intervention for paediatric CHD, providing significant haemodynamic improvement and bridging to definitive surgical management.
- 1 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 380-385
The role of interatrial stenting in the management of CHD
Background: Interatrial stenting has become an essential intervention for children with CHD requiring sustained interatrial communication to optimise systemic and pulmonary haemodynamics. This study aimed to evaluate procedural success, clinical outcomes, and factors influencing haemodynamic improvement in a single-centre paediatric cohort. Methods: A retrospective study was conducted on 16 patients who underwent interatrial stenting between 2018 and 2024. Patients were categorised by age as Group 1 (≤12 months, n = 10) and Group 2 (>12 months, n = 6). Demographic, procedural parameters, and follow-up data were analysed. Results: Sixteen patients (median age 10.5 months, median weight 5.0 kg) underwent interatrial stenting. The most frequent diagnosis was borderline left ventricle (37.5%), followed by hypoplastic left heart syndrome (25%) and myocarditis (12.5%). Procedural success was achieved in 15 of 16 patients (93.8%), with one acute failure due to stent embolisation. The median radiation exposure was 244.5 mGy (interquartile range 123.8–447.0). Radiation exposure correlated positively with patient weight (r s = 0.596, p = 0.015). During a median follow-up of 17.5 months, six patients (37.5%) died, and two required redilation. No stent thrombosis occurred. Conclusion: Interatrial stenting is a safe and effective palliative intervention for paediatric CHD, providing significant haemodynamic improvement and bridging to definitive surgical management.
- Open Access
- 9 January 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (1) , 56-58
An unusual application of percutaneous pulmonary valve implantation in congenitally corrected transposition of the great arteries
An unusual application of percutaneous pulmonary valve implantation in congenitally corrected transposition of the great arteries - Turkish Journal of Thoracic and Cardiovascular Surgery
- 9 January 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (1) , 56-58
Open AccessAn unusual application of percutaneous pulmonary valve implantation in congenitally corrected transposition of the great arteries
An unusual application of percutaneous pulmonary valve implantation in congenitally corrected transposition of the great arteries - Turkish Journal of Thoracic and Cardiovascular Surgery
- Open Access
- 9 January 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (1) , 59-62
Transcatheter closure of the right atrioventricular valve in a double-inlet left ventricle patient following fontan operation
Transcatheter closure of the right atrioventricular valve in a double-inlet left ventricle patient following fontan operation - Turkish Journal of Thoracic and Cardiovascular Surgery
- 9 January 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (1) , 59-62
Open AccessTranscatheter closure of the right atrioventricular valve in a double-inlet left ventricle patient following fontan operation
Transcatheter closure of the right atrioventricular valve in a double-inlet left ventricle patient following fontan operation - Turkish Journal of Thoracic and Cardiovascular Surgery